By Nick Budnick, The Oregonian
Technology to replace the aortic valve without open heart surgery continues to prove itself, new research shows.
People implanted with the transcather aortic valve replacement device called Sapien had a similar death rate three years afterward to those who had heart surgery instead, according to a clinical trial presented Monday at a meeting of the American College of Cardiology.
The device, made by Edwards Lifesciences Corp, lets surgeons replace the aortic valve by threading instruments through an artery in the groin area. Already used in Europe, the device was initially approved in the U.S. only for people too fragile for conventional surgery.
Read the rest of the article on Oregonlive.com
Providence Cancer Center joins global collaboration, taking cancer treatment research to a new level. More »
Join Providence Cancer Center as our specialized cancer care teams discuss causes, prevention and treatment. More »
Telestroke puts stroke experts “in the room” 24/7. More »
Stroll through a magical winter land and ring in the holiday season! More »
Enter your ZIP to see local news and info
Video: Learn important information about our surgical care and meet some of our outstanding surgical staff.Learn More »
Providence St. Vincent Medical Center is home to the world’s most advanced operating suite for brain tumors.More »